NO913186D0 - Fremgangsmaate for anvendelse og syntese av peptider. - Google Patents

Fremgangsmaate for anvendelse og syntese av peptider.

Info

Publication number
NO913186D0
NO913186D0 NO1991913186A NO913186A NO913186D0 NO 913186 D0 NO913186 D0 NO 913186D0 NO 1991913186 A NO1991913186 A NO 1991913186A NO 913186 A NO913186 A NO 913186A NO 913186 D0 NO913186 D0 NO 913186D0
Authority
NO
Norway
Prior art keywords
peptides
synthesis
procedure
mixture
specific binding
Prior art date
Application number
NO1991913186A
Other languages
English (en)
Other versions
NO301279B1 (no
NO913186L (no
Inventor
Hendrik Mario Geysen
Original Assignee
Coselco Mimotopes Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coselco Mimotopes Pty Ltd filed Critical Coselco Mimotopes Pty Ltd
Publication of NO913186D0 publication Critical patent/NO913186D0/no
Publication of NO913186L publication Critical patent/NO913186L/no
Publication of NO301279B1 publication Critical patent/NO301279B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
NO913186A 1989-02-17 1991-08-15 Immobiliserte peptid-faststoffbærerpreparater, og fremgangsmåter for fremstilling av peptider NO301279B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ278889 1989-02-17
PCT/AU1990/000062 WO1990009395A1 (en) 1989-02-17 1990-02-16 Method for the use and synthesis of peptides

Publications (3)

Publication Number Publication Date
NO913186D0 true NO913186D0 (no) 1991-08-15
NO913186L NO913186L (no) 1991-08-15
NO301279B1 NO301279B1 (no) 1997-10-06

Family

ID=3773722

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913186A NO301279B1 (no) 1989-02-17 1991-08-15 Immobiliserte peptid-faststoffbærerpreparater, og fremgangsmåter for fremstilling av peptider

Country Status (12)

Country Link
US (2) US5539084A (no)
EP (2) EP0628570A1 (no)
JP (1) JPH04504416A (no)
AT (1) ATE123780T1 (no)
AU (1) AU642403B2 (no)
CA (1) CA2047191A1 (no)
DE (1) DE69020143T2 (no)
DK (1) DK0458841T3 (no)
ES (1) ES2075196T3 (no)
NO (1) NO301279B1 (no)
NZ (1) NZ232562A (no)
WO (1) WO1990009395A1 (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576424B2 (en) 1989-06-07 2003-06-10 Affymetrix Inc. Arrays and methods for detecting nucleic acids
US6600031B1 (en) 1989-06-07 2003-07-29 Affymetrix, Inc. Methods of making nucleic acid or oligonucleotide arrays

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
DK0486526T3 (da) * 1989-08-07 1996-06-24 Peptide Technology Ltd Bindingsligander for tumornekrosefaktor
US20030225254A1 (en) * 1989-08-07 2003-12-04 Rathjen Deborah Ann Tumour necrosis factor binding ligands
US5959087A (en) * 1989-08-07 1999-09-28 Peptide Technology, Ltd. Tumour necrosis factor binding ligands
DE3935572A1 (de) * 1989-10-25 1991-05-02 Biotechnolog Forschung Gmbh Verfahren zur peptidsynthese und traeger dafuer
US20010021513A1 (en) * 1991-11-21 2001-09-13 Puijk Wouter Cornelis Test device comprising a plate containing a multiplicity of wells with an associated metering device, as well as a kit which comprises these devices and use of the devices
ATE184611T1 (de) * 1991-11-29 1999-10-15 Hoechst Ag Peptide mit insulinartiger wirkung
AU4580093A (en) * 1992-07-22 1994-02-14 Proteus Molecular Design Limited Polypeptide antigens of mycobacterium bovis
US5567391A (en) * 1992-10-08 1996-10-22 Warner-Lambert Company Apparatus for multiple simultaneous synthesis
US5324483B1 (en) * 1992-10-08 1996-09-24 Warner Lambert Co Apparatus for multiple simultaneous synthesis
US5714127A (en) * 1992-10-08 1998-02-03 Warner-Lambert Company System for multiple simultaneous synthesis
US5702672A (en) * 1992-10-08 1997-12-30 Warner-Lambert Company Apparatus and method for multiple simultaneous synthesis
EP0672049A4 (en) * 1992-11-06 1997-10-15 Chiron Mimotopes Pty Ltd SUPPORT FOR THE SYNTHESIS OF MODULE POLYMERS.
AU689116B2 (en) * 1993-06-21 1998-03-26 Aventisub Ii Inc. Selectively cleavable linkers based on iminodiacetic acid ester bonds
US5380668A (en) * 1993-07-06 1995-01-10 University Of Utah Research Foundation Compounds having the antigenicity of hCG
ATE235504T1 (de) * 1994-12-30 2003-04-15 Chiron Corp Verfahren zur kontrollierten synthese von beliebigen peptidmischungen kodierende polynukleotidmischungen
US5958792A (en) * 1995-06-07 1999-09-28 Chiron Corporation Combinatorial libraries of substrate-bound cyclic organic compounds
US6432716B2 (en) * 1995-10-03 2002-08-13 The Penn State Research Foundation Method to identify a surface-bound molecule
US7517952B1 (en) * 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20060269532A1 (en) * 1997-02-25 2006-11-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030185830A1 (en) * 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20060024301A1 (en) * 1997-02-25 2006-02-02 Corixa Corporation Prostate-specific polypeptides and fusion polypeptides thereof
BR9807265A (pt) * 1997-02-26 2000-05-23 Lilly Co Eli Processo de epoxidação seletiva para preparação de compostos farmacêuticos
US7335351B2 (en) * 1997-03-19 2008-02-26 The University Of Arkansas For Medical Sciences Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
US6294344B1 (en) * 1997-03-19 2001-09-25 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US7282198B2 (en) * 1997-03-19 2007-10-16 The University Of Arkansas For Medical Sciences Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
US7084239B1 (en) * 1997-10-08 2006-08-01 The United States Of America As Represented By The Department Of Health And Human Services Cancer peptides of NY-ESO-1/CAG-3
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6432409B1 (en) * 1999-09-14 2002-08-13 Antigen Express, Inc. Hybrid peptides modulate the immune response
US9289487B2 (en) * 1999-09-14 2016-03-22 Antigen Express, Inc. II-key/antigenic epitope hybrid peptide vaccines
US20030235594A1 (en) * 1999-09-14 2003-12-25 Antigen Express, Inc. Ii-Key/antigenic epitope hybrid peptide vaccines
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6656700B2 (en) 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
AU2001272203A1 (en) * 2000-07-14 2002-01-30 Mimotopes Pty Ltd Activated modular grafted polymeric surfaces
JP4503801B2 (ja) * 2000-09-08 2010-07-14 独立行政法人科学技術振興機構 新規ヒト癌・精巣抗原及びその遺伝子
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
CA2427340C (en) * 2000-10-31 2013-09-10 Zycos Inc. Cyp1b1 nucleic acids and methods of use
JP2005505242A (ja) * 2001-03-07 2005-02-24 マンカインド コーポレイション 癌用抗新生血管系調製物
US20040078837A1 (en) * 2001-08-02 2004-04-22 Shannon Mark E. Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12
MXPA04008144A (es) * 2002-02-26 2004-11-26 Genencor Int Proteinas de subtilisina carlsberg con inmunogenicidad reducida.
AU2003243151A1 (en) * 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
EP1556072B1 (en) 2002-09-17 2010-05-19 Antigen Express, Inc. Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
US7179645B2 (en) * 2002-09-24 2007-02-20 Antigen Express, Inc. Ii-Key/antigenic epitope hybrid peptide vaccines
US6910785B2 (en) * 2003-01-22 2005-06-28 Cooper Technologies Company Industrial luminaire with prismatic refractor
US20040185499A1 (en) * 2003-03-20 2004-09-23 Jolley Michael E. Method of epitope scanning using fluorescence polarization
US20050095648A1 (en) * 2003-10-30 2005-05-05 Mario Geysen Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
PT1910839T (pt) * 2005-07-27 2016-07-14 Oncotherapy Science Inc Gene tom34 relacionado com o cancro do cólon
ES2507098T3 (es) 2005-11-07 2014-10-14 Indiana University Research And Technology Corporation Análogos de glucagón que muestran solubilidad y estabilidad fisiológicas
CN101578102B (zh) * 2007-01-05 2013-07-17 印第安纳大学研究及科技有限公司 在生理性pH缓冲液中显示增强的溶解性的胰高血糖素类似物
CA2677932A1 (en) 2007-02-15 2008-08-21 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
EP2044949A1 (en) 2007-10-05 2009-04-08 Immutep Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
MX2010004298A (es) * 2007-10-30 2010-05-03 Univ Indiana Res & Tech Corp Compuestos que exhiben actividad antagonista de glucagon y agonista de glp-1.
MX2010004297A (es) 2007-10-30 2010-05-03 Univ Indiana Res & Tech Corp Antagonistas de glucagon.
CN101983066B (zh) * 2008-01-30 2016-06-29 印第安那大学科技研究公司 基于酯的胰岛素前药
AU2009260301B2 (en) * 2008-06-17 2015-09-03 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers
AU2009260302B2 (en) 2008-06-17 2014-10-23 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
CA2729296A1 (en) * 2008-06-17 2010-01-28 Richard D. Dimarchi Gip-based mixed agonists for treatment of metabolic disorders and obesity
US8969288B2 (en) 2008-12-19 2015-03-03 Indiana University Research And Technology Corporation Amide based glucagon and superfamily peptide prodrugs
EP2391748A4 (en) * 2009-01-28 2012-08-01 Antigen Express Inc LI-KEY HYBRID PEPTIDES MODULATING IMMUNE RESPONSE TO FLU
EP2443146B1 (en) 2009-06-16 2016-10-05 Indiana University Research And Technology Corporation Gip receptor-active glucagon compounds
US8703701B2 (en) 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
US8551946B2 (en) 2010-01-27 2013-10-08 Indiana University Research And Technology Corporation Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
US9127088B2 (en) 2010-05-13 2015-09-08 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
RU2012153753A (ru) 2010-05-13 2014-06-20 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Пептиды глюкагонового суперсемейства, обладающие активностью в отношении сопряженных с g-белком рецепторов
MX2012014576A (es) 2010-06-24 2013-02-21 Univ Indiana Res & Tech Corp Profarmacos de peptido de la superfamilia de glucagon basado en amida.
JP5579939B2 (ja) * 2010-10-29 2014-08-27 ロンザ リミテッド ジケトピペラジン形成ジペプチジルリンカー
MY166516A (en) 2010-12-02 2018-07-05 Oncotherapy Science Inc Tomm34 peptides and vaccines including the same
NZ612297A (en) 2010-12-22 2015-10-30 Univ Indiana Res & Tech Corp Glucagon analogs exhibiting gip receptor activity
LT2723367T (lt) 2011-06-22 2017-08-25 Indiana University Research And Technology Corporation Bendri gliukagono/glp-1 receptoriaus agonistai
RU2014101697A (ru) 2011-06-22 2015-07-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Коагонисты рецепторов глюкагона/glp-1
ES2672880T3 (es) 2011-11-17 2018-06-18 Indiana University Research And Technology Corporation Péptidos de la superfamilia de glucagón que muestran actividad de receptor de glucocorticoides
EP2639299A1 (en) 2012-03-16 2013-09-18 Invectys Universal cancer peptides derived from telomerase
CN104583232B (zh) 2012-06-21 2018-04-13 印第安纳大学研究及科技有限公司 展现gip受体活性的胰高血糖素类似物
BR112015023071A2 (pt) 2013-03-14 2017-07-18 Univ Indiana Res & Tech Corp conjugados de insulina-incretina
US9931387B2 (en) 2013-03-28 2018-04-03 Invectys Cancer vaccine for cats
US10138488B2 (en) 2013-03-28 2018-11-27 Invectys Cancer vaccine for dogs
ES2753412T3 (es) 2013-10-28 2020-04-08 Invectys Electrotransferencia génica a las células de la piel
SI3062824T1 (sl) 2013-10-28 2020-04-30 Invectys Cepivo telomeraza kodirajoče DNA
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
US9682123B2 (en) 2013-12-20 2017-06-20 The Trustees Of Columbia University In The City Of New York Methods of treating metabolic disease
JP6657230B2 (ja) 2014-09-24 2020-03-04 インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション インクレチン−インスリンコンジュゲート
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer
US11119104B2 (en) 2015-08-12 2021-09-14 The Trustees Of Columbia University In The City Of New York Methods of treating volume depletion and kidney injury
EP3622078A1 (en) 2017-05-09 2020-03-18 Invectys Recombinant measles vaccine expressing htert

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983001A (en) * 1972-05-10 1976-09-28 Ceskoslovenska Akademie Ved Isolation of biologically active compounds by affinity chromatography
US3988307A (en) * 1974-09-06 1976-10-26 The United States Of America As Represented By The Secretary Of The Department Of Health, Education And Welfare Solid phase synthesis of peptides with carboxyl-terminal amides
US5133866A (en) * 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US5217869A (en) * 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US4963263A (en) * 1988-03-24 1990-10-16 Terrapin Technologies, Inc. Method of identity analyte-binding peptides
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5340474A (en) * 1988-03-24 1994-08-23 Terrapin Technologies, Inc. Panels of analyte-binding ligands

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576424B2 (en) 1989-06-07 2003-06-10 Affymetrix Inc. Arrays and methods for detecting nucleic acids
US6600031B1 (en) 1989-06-07 2003-07-29 Affymetrix, Inc. Methods of making nucleic acid or oligonucleotide arrays

Also Published As

Publication number Publication date
EP0458841A4 (en) 1992-08-26
WO1990009395A1 (en) 1990-08-23
DE69020143T2 (de) 1996-01-25
DE69020143D1 (de) 1995-07-20
ATE123780T1 (de) 1995-06-15
ES2075196T3 (es) 1995-10-01
DK0458841T3 (da) 1995-11-20
EP0458841A1 (en) 1991-12-04
EP0458841B1 (en) 1995-06-14
US5783674A (en) 1998-07-21
AU642403B2 (en) 1993-10-21
JPH04504416A (ja) 1992-08-06
EP0628570A1 (en) 1994-12-14
CA2047191A1 (en) 1990-08-18
AU4986990A (en) 1990-08-23
NO301279B1 (no) 1997-10-06
US5539084A (en) 1996-07-23
NZ232562A (en) 1992-10-28
NO913186L (no) 1991-08-15

Similar Documents

Publication Publication Date Title
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
AU542802B2 (en) Immunoassay for nonenzymatically glucosylated proteins and protein fragments
AU1986588A (en) Growth hormone receptor
PL374311A1 (en) Methods for purifying protein
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
DE3763653D1 (de) Trennungsverfahren fuer kohlenwasserstoffgase.
AU640699B2 (en) Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
ES2173165T3 (es) Metodo para obtener reactivos para diagnosticos, dosificados y terapias basado en la manifestaciones clinicas de una emfermedad.
AU5320086A (en) Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses
CA2220447A1 (en) Novel fusion protein recovery and purification methods
ES2010770A6 (es) Un gel de agarosa de electroforesis de alta resolucion (ear) y el correspomdiente metodo electroforetico para separaa proteinas de suero.
NO882299D0 (no) Fremgangsmaate for magnetisk separering av merket reagens i en immunometrisk bindings-analyse.
EP1304381A3 (en) Process for producing hydrophobic polypeptides, proteins or peptides
DE69232801T2 (de) Abtrennungsverfahren
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
EP0239311A3 (en) Mutual separation of proteins
PL316126A1 (en) Method of obtaining immunoproteins from fractions emerging in a human blood serum fractioning process
GB9816514D0 (en) Novel method
DE68903429D1 (de) Vorrichtung zur trennung von gasmischungen.
EP0351804A3 (en) Hcg peptides for use in antibody purification procedures
DE69534178D1 (en) S?ugetier thymokingene
ATE193021T1 (de) Lipoprotein (a)-peptide und deren verwendung